While only two drug-eluting coronary stents are currently cleared for sale in the U.S., numerous others are peeking over the horizon, awaiting their turn in the sun. The existing products and those that are on the way reflect a variety of different approaches in terms of both the drugs and the polymer coatings chosen by the companies vying for a spot in the marketplace.